Investing Eli Lilly Stock Declines as Patients Experience Weight Gain Following Discontinuation of Zepbound December 12, 2023
Investing Eli Lilly Secures FDA Approval for Obesity Drug Competing with Wegovy and Ozempic November 8, 2023